US patients aged 10 years and older can now benefit from FARXIGA for type-2 diabetes
Approval based on results from T2NOW, one of the largest pediatric type-2 diabetes Phase III trials to date
.
FARXIGA approved in the US for the treatment of pediatric type-2 diabetes lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
The highest incidence of pediatric type 1 diabetes (T1D) over the past 22 years was seen in Finland, high-income North American regions, and children aged 5 to 14 years.